Non-White Participants Matter in White Matter Disease Studies: The Importance of Diversity in Multiple Sclerosis Clinical Trials

Neurology. 2022 Mar 1;98(9):345-346. doi: 10.1212/WNL.0000000000013224. Epub 2022 Jan 19.

Authors

Roy Hoshi Hamilton¹, Olga Ciccarelli²

Affiliations

¹ From the Department of Neurology (R.H.H.), University of Pennsylvania, Philadelphia; and Department of Neuro-Inflammation (O.C.), University College London, UK. roy.hamilton@pennmedicine.upenn.edu.
² From the Department of Neurology (R.H.H.), University of Pennsylvania, Philadelphia; and Department of Neuro-Inflammation (O.C.), University College London, UK.

PMID: 35046136
DOI: 10.1212/WNL.0000000000013224

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Leukoencephalopathies*
Magnetic Resonance Imaging
Multiple Sclerosis* / drug therapy
White Matter* / diagnostic imaging